A Prospective, Observational and Multicentric Study to Evaluate the Performance and Clinical Utility of EndoID ELISA Kit to Determine Circulating Synuclein Gamma (SNCG) and B-cell Lymphoma-6 (BCL6) Levels as Potential Biomarkers for Endometriosis
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
Endometriosis is a condition in which tissue similar to the lining of the uterus grows outside the uterus, often causing pain and infertility. Currently, endometriosis can only be definitively diagnosed through invasive procedures like laparoscopy and biopsy. The purpose of this study is to investigate whether the proteins Synuclein Gamma (SNCG) and B-Cell Lymphoma 6 (BCL6), measurable in blood and menstrual fluid, can serve as non-invasive biomarkers to diagnose or monitor endometriosis.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 45
Healthy Volunteers: t
View:
• Women of reproductive age group (18Y-45Y).
• Women with active endometriosis diagnosed by ultrasound/MRI/laparoscopy.
• Women of reproductive age group (18Y-45Y).
• Women without endometriosis and any other gynaecological problem.
Locations
Other Locations
Canada
Trio Fertility
RECRUITING
Toronto
Contact Information
Primary
Yasaman Sadeghi, M.Sc.
yasamans@triofertility.com
4165060804
Time Frame
Start Date: 2026-01-16
Estimated Completion Date: 2027-09-01
Participants
Target number of participants: 100
Treatments
Endometriosis Group
Patients who have been diagnosed with Endometriosis
Control Group
Patients who have not been diagnosed with Endometriosis
Related Therapeutic Areas
Sponsors
Leads: Trio Fertility